Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions

Completed · Not applicable

Conditions studied: Pancreatic Cancer

In brief

This study will test the amount of tissue, called "cell block", obtained from your pancreas. Patients who are asked to participate in this study have a growth (mass) in the pancreas that needs a biopsy so a diagnosis can be made. Although we usually perform 2 to 4 passes (number of times the doctor biopsies the mass), at this time we do not know the ideal number of passes needed to obtain adequate amount of tissue for making a diagnosis. The purpose of this study is to compare the amount of tissue obtained with 2 passes versus 4 passes.

Key facts

Study ID

NCT01809028

Run by

AdventHealth

People needed

62

Starts

2013-02-01

Expected to finish

2014-01-01

Last updated by the study team

2017-08-03

Who can join

Age: 19 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients referred to Florida Hospital Endoscopy Unit for assessment of pancreatic mass lesions that require FNA.

You may not qualify if…

• Age <19 years
• Unable to safely undergo EUS for any reason
• Coagulopathy (INR >1.6, Prothrombin Time >18secs, Thrombocytopenia <80,000 cells/ml)
• Unable to consent
• Non-English speaking patients.
• Participation in any other Clinical Trial (excluding registries and databases)

Where it is running

• Florida Hospital — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.